US Broker Ratings

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring a 140% Upside Potential in Biotech

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands out in the biotechnology sector, offering investors a compelling opportunity with a potential upside of 140.56%. With a market capitalization of $3.63 billion, Crinetics..

Ascentage Pharma Group (AAPG) Stock Analysis: A Biotech with 120% Potential Upside

Ascentage Pharma Group International (AAPG) is capturing the attention of investors with its promising outlook in the biotechnology industry, particularly due to its potential upside of 120.17%. Headquartered in Suzhou,..

Evotec SE (EVO) Stock Analysis: Exploring a 120% Potential Upside Amidst Challenging Metrics

Evotec SE (EVO), a German-based drug discovery and development company, stands at a pivotal juncture in its financial trajectory. With a market capitalization of $852.63 million and a recent price..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Powerhouse with 22% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a formidable player in the biotechnology sector, captivating investor interest with its diverse portfolio of biopharmaceutical assets. Based in Jupiter, Florida, Ligand develops..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Unpacking the 252% Potential Upside for Investors

For investors with an eye on the biotechnology sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) stands out as a compelling prospect. With a market capitalization of $761.61 million, this San Diego-based..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Analyst Optimism Points to Significant Upside Potential

Dyne Therapeutics, Inc. (NASDAQ: DYN) is making waves in the biotechnology sector with its ambitious pipeline targeting neuromuscular diseases. Operating from Waltham, Massachusetts, this clinical-stage company is gaining attention for..

Sotera Health Company (SHC) Stock Analysis: 49.5% Potential Upside Captures Investor Attention

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector with its innovative sterilization solutions and lab testing services. As a key player in the Diagnostics & Research industry,..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Biotech Gem with 55.90% Potential Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) presents an intriguing opportunity for investors keen on the biotechnology sector. With a current market cap of $2.76 billion, this healthcare player is making significant..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech Gem with a 288% Upside Potential

Janux Therapeutics, Inc. (NASDAQ: JANX) is making waves in the biotech sector with its innovative approach to cancer treatment and promising financial outlook. Based in San Diego, California, Janux is..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Strong Revenue Growth and Analyst Confidence Highlight Investment Potential

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the healthcare sector with a robust portfolio in the medical instruments and supplies industry. With a market capitalization of $2.46 billion, this..

Harmony Biosciences Holdings (HRMY) Stock Report: Analyzing the 52.17% Potential Upside for Investors

Harmony Biosciences Holdings Inc. (NASDAQ: HRMY), a key player in the biotechnology sector, has emerged as a compelling investment opportunity for those keen on the dynamic healthcare industry. This commercial-stage..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unpacking the 100% Potential Upside

Alphatec Holdings, Inc. (NASDAQ: ATEC), a dynamic player in the healthcare sector, is making waves in the medical devices industry. With a focus on innovative technologies for spinal surgery, this..

DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Unpacking a 25.96% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the medical instruments and supplies industry, is drawing attention with its substantial potential upside of 25.96%. This potential growth, alongside a..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 41.62% Potential Upside in the Diagnostics Sector

For investors with a keen interest in the healthcare sector, Veracyte, Inc. (VCYT) offers a compelling opportunity with a noteworthy potential upside of 41.62%. Specializing in diagnostics and research, Veracyte..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 65% Potential Upside in the Booming Biotech Sector

Investors with an eye on the healthcare sector may find Immunovant, Inc. (NASDAQ: IMVT) an intriguing opportunity. This clinical-stage biotechnology firm, based in New York and a subsidiary of Roivant..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 71.91% Potential Upside

UFP Technologies, Inc. (NASDAQ: UFPT) stands out in the healthcare sector, particularly within the medical devices industry, as it continues to pique investor interest with its innovative solutions and promising..

SS Innovations International (SSII) Stock Analysis: Revenue Soars with Innovative Surgical Solutions

SS Innovations International Inc. (SSII), trading on the Indian market, is carving its niche in the healthcare sector with a market capitalization of approximately $980.64 million. As a commercial-stage surgical..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 100.72% Upside Potential in the Medical Devices Sector

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector, has been drawing attention with its noteworthy potential upside of 100.72%. As a medical technology company, Enovis focuses on..

CRISPR Therapeutics AG (CRSP) Stock Analysis: A Deep Dive into its 79% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering company in the gene-editing landscape, presents a compelling investment case with a potential upside of 79.09%, according to the latest analyst ratings. This..

Metsera, Inc. (MTSR)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds